← Browse by Condition
Medical Condition
amyotrophic lateral sclerosis
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 4, Phase 1
ClinicalMetric tracks all active clinical trials for amyotrophic lateral sclerosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — amyotrophic lateral sclerosis Clinical Trials
How many clinical trials are currently recruiting for amyotrophic lateral sclerosis?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for amyotrophic lateral sclerosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for amyotrophic lateral sclerosis?
amyotrophic lateral sclerosis research spans Phase 1 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a amyotrophic lateral sclerosis clinical trial?
Eligibility criteria for amyotrophic lateral sclerosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06596746
Recruiting
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Enrollment
600 pts
Location
Italy
Sponsor
Casa di Cura San Raffaele Cass...
NCT07357428
Recruiting
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Enrollment
2 pts
Location
United States
Sponsor
Paradromics
NCT00801333
Recruiting
Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells
Enrollment
25 pts
Location
Israel
Sponsor
Hadassah Medical Organization
NCT06021938
Recruiting
Alleviating Persistent Dyspnea in Amyotrophic Lateral Sclerosis Patients Treated With Non-Invasive Ventilation Through Immersive Virtual Reality
Enrollment
35 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT07223723 Phase 4
Recruiting
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)
Enrollment
12 pts
Location
China
Sponsor
Biogen
NCT07193953 Phase 1
Recruiting
Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)
Enrollment
6 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
NCT05747937
Recruiting
Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS
Enrollment
100 pts
Location
Italy
Sponsor
Istituti Clinici Scientifici M...
NCT03225144
Recruiting
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Enrollment
360 pts
Location
United States
Sponsor
National Institute of Neurolog...
NCT00317616
Recruiting
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
Enrollment
500 pts
Location
United States
Sponsor
University of Miami
NCT02795052
Recruiting
Neurologic Stem Cell Treatment Study
Enrollment
500 pts
Location
United States, Unite...
Sponsor
MD Stem Cells
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology